Journal Articles

Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety

PAIN, September 2020

Large JPG-20140228_Trade 151_0046.jpg

Comparison of a Pain Tolerability Question With the Numeric Rating Scale for Assessment of Self-reported Chronic Pain

JAMA, April 2020

AAPT Diagnostic Criteria for Chronic Low Back Pain

Journal of Pain, 2020

Association Between Opioid Use and Patient-Reported Outcomes in a Randomized Trial Evaluating Basivertebral Nerve Ablation for the Relief of Chronic Low Back Pain

Neurosurgery, March 2020

SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back pain

PAIN, June 2019

Extended-release gabapentin for failed back surgery syndrome: results from a randomized double-blind cross-over study

PAIN, May 2019

Why are there no drugs indicated for sciatica, the most common chronic neuropathic syndrome of all?

Drug Discovery Today, November 2018

Large JPG-20140228_Trade 151_0046.jpg

Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial

Journal of Neurology, September 2018

Effects of Pregabalin in Patients with Neuropathic Pain Previously Treated with Gabapentin: A Pooled Analysis of Parallel-Group, Randomized, Placebo-controlled Clinical Trials

Pain Practice, July 2017

Evaluation of outcome measures for neurogenic claudication: A patient-centered approach

Neurology, October 2015